PaxMedica, Inc. (NASDAQ:PXMD) Short Interest Update

PaxMedica, Inc. (NASDAQ:PXMD) saw a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 637,700 shares, an increase of 377.0% from the March 31st total of 133,700 shares. Approximately 9.4% of the company’s shares are sold short. Based on an average daily trading volume, of 2,330,000 shares, the days-to-cover ratio is currently 0.3 days.

PaxMedica Price Performance

Shares of PaxMedica stock traded up $0.01 during trading on Thursday, hitting $0.70. The stock had a trading volume of 214,987 shares, compared to its average volume of 1,926,746. PaxMedica has a 12 month low of $0.37 and a 12 month high of $29.75. The firm’s fifty day simple moving average is $0.62 and its 200-day simple moving average is $1.23. The stock has a market cap of $5.26 million, a PE ratio of -0.03 and a beta of 0.61.

About PaxMedica

PaxMedica, Inc, a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for the treatment of autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human African trypanosomiasis (HAT).